Social and ethical issues arise beyond potential for preventing rare complex diseases
Sophisticated prenatal techniques, not yet in clinical practice, offer the potential to prevent a cruel multi-system genetic disease passing from mother to child long before birth.
But these emerging tools raise important questions: might there be unintended, even irreversible risks to the resulting child–or even that child’s future descendants? Are there potential risks to the mother’s health? What about other potential consequences if its use is broadened to include indications beyond strict disease prevention, such as adapting the tools into conception aids for older women?
The tools in question, mitochondrial replacement techniques (MRTs), aim to prevent mother-to-child transmission of mitochondrial DNA disease –a complex set of rare disorders caused by defective DNA within the mitochondria, the tiny energy-producing structures existing outside the nucleus of cells. Such disease may present at any age or level of severity, attacking a combination of organs and systems, often fatally. There are no current cures or approved therapies for any of these disorders, which clinicians manage by treating the diverse symptoms that may progressively affect each patient.
Earlier this month, an expert panel of national experts formed by the Institute of Medicine at the request of the U.S. Food and Drug Administration (FDA) recommended that research into MRTs should proceed under carefully proscribed guidelines.
Three members of that panel co-authored a Perspective article in today’s New England Journal of Medicine on MRT’s implications for clinicians. The article begins, “Mitochondrial DNA (mtDNA) disease may be the poster child for highly targeted, ‘personalized’ medicine.”
“Even though MRTs would not confer health benefits on patients who already have mitochondrial DNA diseases, many patients with a known risk for transmitting such a disease to their offspring are highly motivated to prevent that from occurring,” said Marni J. Falk, M.D., director of the Mitochondrial-Genetics Clinic at The Children’s Hospital of Philadelphia and first author of the article. “That motivation is clear when we counsel patients and families affected by mtDNA disease, and recent patient surveys have reinforced that preventing disease transmission is a prevailing concern in this population.”
Falk’s co-authors are Jeffrey Kahn, Ph.D., M.P.H., of the Johns Hopkins Berman Institute of Bioethics, and Alan Decherney, M.D., an obstetrician-gynecologist and reproductive endocrinologist at the National Institute of Child Health and Human Development.
Kahn chaired the Institute of Medicine expert panel.
Because the expert panel stated that the child’s safety was paramount, it recommended that MRTs should initially be studied only in male embryos, since males do not transmit mitochondrial DNA to their children. The panel further argued that the FDA should make clear policy and that professional societies should issue practice recommendations to limit future MRT usage to appropriate patients.
The authors repeat the panel’s stipulation that children conceived after MRT should be monitored long-term, “probably well into adulthood,” much longer than is done after in vitro fertilization with pre-implantation diagnosis for diseases based in nuclear DNA.
Finally, because MRTs require mixing mitochondrial DNA from a female donor with DNA from the nucleus of the mother and father, the authors note that researchers should investigate unanticipated health problems and possibly questions about identity, before regulatory approval or clinical use can occur for the techniques.
The Latest on: Mitochondrial DNA replacement
via Google News
The Latest on: Mitochondrial DNA replacement
- Mitochondria-encoded genes contribute to evolution of heat and cold tolerance in yeaston March 5, 2021 at 4:00 pm
The screen identified only a single nuclear-encoded gene with a moderate effect on heat tolerance, but, in contrast, revealed a large effect of mitochondrial DNA (mitotype) on both heat and cold ...
- Advanced imaging technology captures translation of the maternal genomeon February 22, 2021 at 3:37 pm
Researchers have captured ribosomes translating messenger RNA expressed from the maternally inherited mitochondrial genome ... As modern archaeology reveals, the DNA that encodes genes can ...
- Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathyon February 18, 2021 at 12:34 am
Cleaved AIF translocated to the myocyte nucleus triggering large-scale DNA fragmentation and cell death, an effect potentiated by mitochondrial-driven AIF ... encompass myocyte apoptosis and necrosis ...
- Platelets release mitochondrial antigens in systemic lupus erythematosuson February 10, 2021 at 4:00 pm
Mitochondrial release in patients with SLE correlates ... can further induce somatic replacement mutation in DNA-reactive B cells and promote generation of high affinity anti-DNA antibodies (19).
- Phosphorylation and chromatin tethering prevent cGAS activation during mitosison February 2, 2021 at 4:00 pm
The N terminus of cGAS was critical for sensing nuclear chromatin, but not mitochondrial DNA. Chromatin sensing was blocked by hyperphosphorylation. Secondly, oligomerization of chromatin-bound cGAS, ...
- Mitochondrial DNA and temperature tolerance in lager yeastson February 2, 2021 at 4:00 pm
The mitochondrial climatic adaptation hypothesis (1) posits that functional variation between mitochondrial DNA (mtDNA) sequences (mitotypes) plays an important role in shaping the genetic adaptation ...
- Drug Insight: Antioxidant Therapy in Inherited Ataxiason January 20, 2021 at 4:00 pm
is caused by deficiency of a mitochondrial protein, frataxin, which has direct antioxidant and iron-regulatory functions, making this disease a prime candidate for antioxidant therapy Clinical ...
- Systematic parasitologyon January 19, 2021 at 4:00 pm
and phylogenetic position inferred from mitochondrial DNA sequences of the 16S rRNA gene. Choanotrema nom. nov. (Trematoda: Opecoelidae), a new replacement name for Choanostoma Yamaguti ...
- Medical Genetics and Genomics Trainee Publicationson August 30, 2020 at 3:38 pm
PMID: 31696996 Multiple mitochondrial dysfunctions syndrome 1 ... PMID: 31757659 Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders. Schaser ...
- Leigh Syndromeon February 29, 2020 at 6:35 pm
Nearly 20% of these genes are located in mitochondrial DNA that is associated with energy production ... His mitochondrial disease was stabilized, and he underwent kidney replacement after extensive ...
via Bing News